Researchers used TriNetX a global health research network that aggregates deidentified data from more than 275 million people to identify individuals for the study
Rights and permissions About this article Cite this article Drucker, D.J., Rosen, C.F
The peptide is intended solely for scientific investigation of melanocortin signaling pathways
Note that Ozempic was first developed in 2012 and has only been available in the U.S
Authors reported small statistically significant differences in weekly weight loss at the 1 mg dose with a non-linear dose response, but the abstract data has not been published in full peer-reviewed form
GLP-1s Are Already Used by More People with AUD Than Legacy SUD Treatments Crucially, GLP-1s already have an established history of use in patients with substance use disorders, simply because such a large percentage of the population is taking a GLP-1 for other conditions